Detalhe da pesquisa
1.
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys.
Drug Dev Ind Pharm
; 45(3): 387-394, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30395728
2.
The Serratia LuxR family regulator CarR 39006 activates transcription independently of cognate quorum sensing signals.
Mol Microbiol
; 80(4): 1120-31, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21435033
3.
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease.
Sci Rep
; 11(1): 19422, 2021 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34593832
4.
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients.
Sci Rep
; 9(1): 14042, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31575982
5.
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease.
Sci Rep
; 8(1): 4941, 2018 03 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29563546
6.
Engineering of new prodigiosin-based biosensors of Serratia for facile detection of short-chain N-acyl homoserine lactone quorum-sensing molecules.
Environ Microbiol Rep
; 2(2): 322-8, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23766084
7.
Ferrichrome utilization in a mesorhizobial population: microevolution of a three-locus system.
Environ Microbiol
; 9(12): 2923-32, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17991023